{"name":"Abivax S.A.","slug":"abivax-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"ABX464","genericName":"ABX464","slug":"abx464","indication":"Inflammatory bowel disease (Crohn's disease)","status":"phase_3"},{"name":"ABX464 Repeated dose","genericName":"ABX464 Repeated dose","slug":"abx464-repeated-dose","indication":"Treatments for autoimmune diseases","status":"phase_1"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ABX196","genericName":"ABX196","slug":"abx196","indication":"Other","status":"phase_1"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"ABX464 Single dose","genericName":"ABX464 Single dose","slug":"abx464-single-dose","indication":"HIV infection","status":"phase_1"}]}],"pipeline":[{"name":"ABX196","genericName":"ABX196","slug":"abx196","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABX464","genericName":"ABX464","slug":"abx464","phase":"phase_3","mechanism":"ABX464 is a small molecule that modulates RNA splicing to promote the production of anti-inflammatory isoforms of proteins involved in immune regulation.","indications":["Inflammatory bowel disease (Crohn's disease)","HIV infection"],"catalyst":""},{"name":"ABX464 Repeated dose","genericName":"ABX464 Repeated dose","slug":"abx464-repeated-dose","phase":"phase_1","mechanism":"ABX464 is a small molecule antagonist of RARγ","indications":["Treatments for autoimmune diseases"],"catalyst":""},{"name":"ABX464 Single dose","genericName":"ABX464 Single dose","slug":"abx464-single-dose","phase":"phase_1","mechanism":"ABX464 is a small molecule that modulates the RNA splicing process to inhibit HIV replication.","indications":["HIV infection"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxPMXkycDRjeU9tdUctbFc0a1ZBclRVRE8tZ2hhczRscVBOR3dWbUdISkRaOXdoVVYweVNoMF9xTVpoUHhLaFM1QzFiR29XZUczWUVlNG15cE1fZk1TU1pTUFlJOF9iS2VPSVk2cC0xbzlUWGxzZFAtYTE0SDRuRFhILXZTMTlpVkJ6WnVzaXVOTjc2aXcwZ1BYTDIzSnZacUlQZ3BfMndOamNxdHMzcEhhaTJSc0ZBcXNRelB6NU5XR1J6MXFSdjZwckZmQVEzWG90Si1xUGVIc1lFSnpJZ05leUJ5MnlLSS1LcVliVklJaVpNSkVNUkotdzFRejJHN3ZTV1QzYlhBNmhHNGc3bDdQWXdLRDhhRmxvZ3ZhWEJKc25fU212ZzZXTU9mOXBydXM?oc=5","date":"2026-03-25","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1QelFpRzdDWGhHMWJvYmRyTG5ZTG1iVTdta2dCRVVjTGpIdkd2Z0dQVC13Y29SZWVDaThHOWFNalJ2QmIyYmYwMmllSzdLbGdVSVZFRExMTTh4OXlo?oc=5","date":"2026-03-13","type":"pipeline","source":"TradingView","summary":"ABVX Stock Price and Chart — NASDAQ:ABVX - TradingView","headline":"ABVX Stock Price and Chart — NASDAQ:ABVX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE82ay1kRlVDSlF2XzE1NENTM0UzWlh6Sy14MFVwS0pkQkpHTVJvSS1vY19DSTdfY1VWTVBhX2tTQ0NyTUZ4UjM5eWhfZXRrRjJuaVlsZTByMHR3MTE2WllV?oc=5","date":"2026-03-13","type":"pipeline","source":"TradingView","summary":"ABVX Stock Price and Chart — EURONEXT:ABVX - TradingView","headline":"ABVX Stock Price and Chart — EURONEXT:ABVX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5iMnB6d0RtaUtZcG5TTURBSFktUHN4X1Y5MFdZdG9jbHNNdGVoRW14Nzd6bHc4dzlTV2ZXa05YRm9wRjhLUGFvRmhRYXVIaVRQQzU3RC1iVEdPb1RGNEtTVDlYemFPUTJwYTQ0VTJ3dkhKR0ZQWmV6X2dn?oc=5","date":"2026-01-21","type":"pipeline","source":"BioCentury","summary":"Biotech’s year of the launch - BioCentury","headline":"Biotech’s year of the launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQLUQ1OE55Mk9aVVkycjFzRXE0dXNPVFVxbk9iYU9vdGFQQnp5Rk0zVFNucVlfUkxLc3FzVHBxT1RDYUl6cExZbjlOaGNhMlloaWEyVXRCM2M3V2lfYncyUk55b1RWNVhnb1UtTjBodU5wZ0lIX3VLNTU1a0JiZUZ5TkJDcFJfeXNubDZHMklTNWYxQlNRWlFZ?oc=5","date":"2026-01-15","type":"deal","source":"BioWorld News","summary":"Muted and missing M&As: JPM deals absent in 2026 - BioWorld News","headline":"Muted and missing M&As: JPM deals absent in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNcnc0VWJfWXpQaW9jLTF3QlNtTDhvN09Kdm5nOUdMYy13cE1UTnQ1V0JsSlBDS1ZKSThhUXJDRWlzNkNnLTRGeGs2b0RVWjJlUEU1Unc0WTRYdm1PRGMtYkNBTGEteXBKbkNxb0h6ZVhHdUU2WW00UG53MmdNZUR6am5Ya093cE9SWXdUNXdsQXdFQnFtSGNCRDIwaEltMmo2azFaYVBqRlFaN1pPVmE4MEZB?oc=5","date":"2026-01-12","type":"pipeline","source":"bloomberg.com","summary":"Abivax CEO Says Big Pharma Can’t Ignore Its Experimental Drug - bloomberg.com","headline":"Abivax CEO Says Big Pharma Can’t Ignore Its Experimental Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNREdzaHEwSkpGbUJuTWJRUXpodUdKNEZhY282OGZ0UXhOWUFTM25ib0lualNaenBHSDBiNWVqZXVCYU9PR0tSS2ZGOTZwaG1pNzRiMDEtVHMzdzlQZWc5ZU41Y082TUFYUUdIOFpzUFA4ZUwzb0c2OEgyeWVkeHk2MGx6YXFzVEJHMGhoV3NiWnhhZFhsOXZpU294ZEJGLWJ1a0I1Q01NTWJfUGdqVDVjN3ZJaUs0ajd1dUdfZmkwM1ZOTmRpMkE?oc=5","date":"2026-01-12","type":"deal","source":"reuters.com","summary":"France denies contact with Eli Lilly over reported $17.5 bln Abivax deal - reuters.com","headline":"France denies contact with Eli Lilly over reported $17.5 bln Abivax deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxNOGVYSTFhLWRfSFFIS080dzFIbDFnRm5KbF9KVmZOUWFpRkpmVVZydnhiN3lWTkZQS1paTWtJVVBvWHlRVU5GNGYxNlJVQVZ1cVYybTB5UDA0VjlpM21Qdkd6Uk5aZDgzZDBBV05acDdrdHk1S3pwanh5ay1rWE1wWHRRTzJTa3UzX2tyal9lVXhDMFJ2SzVCT3JqbzRmcEc3RUlYZU9oLVF2RWduT1dQZk9qazN5SldQZ1FISnMyd2RlSUlRb2FHdUVDbVRUM3ZNT0Y5UElIUl96Y2dYTEdXMzJuNWpoU2dBSFpBeWtGSWRpZ0tDVjYtNmRKMUd0eVNmeXQ1TE9Tb3BSaHJBdmlLWkNmeUlIMFRodWRrT0VrZFZVcHo4cFlfcVpHdG9TeW1sSkc2TDZCc0F2M01tVUE?oc=5","date":"2025-12-22","type":"pipeline","source":"TechStock²","summary":"ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes EffectABIVAXABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Tal","headline":"ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes Effec","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQOUtFZ0tnQmwzNy1DbzFlY0YySXcwTHBxRkIzdFoyeFNKOEpQd3R4Nzg1eXhvNzUwQ0F4S3B3bWgxemJkcjgyWjRMR2xvTVp3eFlYWnFVN3dHeHJOeUFldHdpRkRqalZCN1VIWWF4STVpUWRmTEFXalpQUHcteWVQclBaNEZBOG1lSWxQZG1wVnZSTXNSdlIxT1FkMVY2UFRVME54VVFuZkdYcDV6Q1hCeWx2SG5ZNTg3WG5hemp3Y19QdXpFaVpB?oc=5","date":"2025-12-10","type":"pipeline","source":"reuters.com","summary":"French biotech Abivax's shares climb on Eli Lilly bid rumors - reuters.com","headline":"French biotech Abivax's shares climb on Eli Lilly bid rumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9BZkhrWTYwaV9tMUM1aVM0ZXJZUUVRa0pMblZNYWFXa19WMkt1WXZVN0o0U2tfZG94NVZIajVNdU9RUlpoaHY2ZWZzdkhKNWtIbl9DQ2tPeF84NWNaLU5ENTd2ekZtSGw5Y3cwV3d2R1VsT202UXc?oc=5","date":"2025-12-10","type":"pipeline","source":"timothysykes.com","summary":"Abivax Unexpected Surge: Market Analysis - timothysykes.com","headline":"Abivax Unexpected Surge: Market Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPeW80c0Fia3d4NEVQRTAySERneURGd2FvYVNCb1JuUWtTRzUtWGV6cmNoQ3dFeGtLV3ItczJxMFhvZ1RCa19ONHQ3d1NLaElSNTFHUzVQb19XUWpUdnJGWHZkdHpvS0pRRThZTWswMW5GQTJJeExMYWN3YUVVUkltc21OdkZBYm1yQldUTVdxWkJ6T3ZzN3BMSzNyRllET2E4SDBzVUVsSEkzdHU3aWxmeVEzWQ?oc=5","date":"2025-12-03","type":"pipeline","source":"bloomberg.com","summary":"Europe’s Biotech Standout Faces Crucial Year After 1,300% Rally - bloomberg.com","headline":"Europe’s Biotech Standout Faces Crucial Year After 1,300% Rally","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNeXRWZDIzc0xLcmVNSEp3V3BVWlE5LU1qZkhyQ2huT1d1TS1HZ2N6aTEtU0ZLRC1rbnk2SW82WmtRbDRTUFRzU2NJbzZVLWJUVjhOM25MbWFDNXk2N3dYQ2s5TDZlNWhibUE2SE13UGxORGlVVklTNnpnTlpxQUxZN0JFZ20?oc=5","date":"2025-11-13","type":"pipeline","source":"Yahoo Finance","summary":"Are Medical Stocks Lagging Abivax SA Sponsored ADR (ABVX) This Year? - Yahoo Finance","headline":"Are Medical Stocks Lagging Abivax SA Sponsored ADR (ABVX) This Year?","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_1":3,"phase_3":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}